Brief: Panacea Biotec Gets $24.32 Mln Award Of Pentavalent Vaccine From U.N. Agencies
19/12/2019 05:15
Dec 19 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* PANACEA BIOTEC LTD SAYS GETS $24.32 MILLION AWARD OF
PENTAVALENT VACCINE FROM U.N. AGENCIES
Source text for Eikon: ID:nBSE8g7vhz
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility